Vertex Pharmaceuticals Inc
Close on Nov 20, 2026Market cap $130.54BP/E 30.0Yield –
Balance Sheet — Total assets của Vertex Pharmaceuticals theo quý
Balance Sheet — Total assets ($M) ($M)
Balance Sheet — Total assets của Vertex Pharmaceuticals: $27,423M trong Q2 2026, tăng 14.1% so với cùng kỳ năm trước. Đó là mức cao nhất trong 67 quý có ở đây.
Số của Q2 2026 lấy từ đâu
Nguồn: Form 10-Q (filed 2026-08-04) ↗
Được báo cáo trong Form 10-Q / 10-K Consolidated Balance Sheets (DB).
Lịch sử theo quý
Rê chuột vào một số để xem câu chữ đã đọc ra số đó; số tự tính sẽ hiện công thức
| Kỳ | Kết thúc | Balance Sheet — Total assets ($M) ($M) | So với cùng kỳ | Nguồn |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 27,423 | +14.1% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2026 | Mar 31, 2026 | 26,484 | +15.8% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2025 | Dec 31, 2025 | 25,643 | +13.8% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2025 | Sep 30, 2025 | 24,862 | +11.8% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2025 | Jun 30, 2025 | 24,037 | +19.4% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 22,881 | -4.3% | Form 10-Q (filed 2025-05-06) ↗ |
| Q4 2024 | Dec 31, 2024 | 22,533 | -0.9% | Form 10-K (filed 2025-02-13) ↗ |
| Q3 2024 | Sep 30, 2024 | 22,240 | +2.4% | Form 10-Q (filed 2024-11-05) ↗ |
| Q2 2024 | Jun 30, 2024 | 20,132 | -1.1% | Form 10-Q (filed 2024-08-02) ↗ |
| Q1 2024 | Mar 31, 2024 | 23,917 | +26.1% | Form 10-Q (filed 2024-05-07) ↗ |
| Q4 2023 | Dec 31, 2023 | 22,730 | +25.2% | Form 10-K (filed 2024-02-15) ↗ |
| Q3 2023 | Sep 30, 2023 | 21,726 | +30.0% | Form 10-Q (filed 2023-11-07) ↗ |
| Q2 2023 | Jun 30, 2023 | 20,349 | +30.6% | Form 10-Q (filed 2023-08-02) ↗ |
| Q1 2023 | Mar 31, 2023 | 18,974 | +33.1% | Form 10-Q (filed 2023-05-02) ↗ |
| Q4 2022 | Dec 31, 2022 | 18,151 | +35.1% | Form 10-K (filed 2023-02-10) ↗ |
| Q3 2022 | Sep 30, 2022 | 16,706 | +32.4% | Form 10-Q (filed 2022-10-28) ↗ |
| Q2 2022 | Jun 30, 2022 | 15,582 | +27.5% | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 14,256 | +17.7% | Form 10-Q (filed 2022-05-06) ↗ |
| Q4 2021 | Dec 31, 2021 | 13,433 | +14.3% | Form 10-K (filed 2022-02-09) ↗ |
| Q3 2021 | Sep 30, 2021 | 12,619 | +11.7% | Form 10-Q (filed 2021-11-03) ↗ |
| Q2 2021 | Jun 30, 2021 | 12,222 | +19.6% | Form 10-Q (filed 2021-07-30) ↗ |
| Q1 2021 | Mar 31, 2021 | 12,115 | +36.2% | Form 10-Q (filed 2021-04-30) ↗ |
| Q4 2020 | Dec 31, 2020 | 11,752 | +41.3% | Form 10-K (filed 2022-02-09) ↗ |
| Q3 2020 | Sep 30, 2020 | 11,302 | +50.4% | Form 10-Q (filed 2020-10-30) ↗ |
| Q2 2020 | Jun 30, 2020 | 10,216 | +45.3% | Form 10-Q (filed 2020-07-31) ↗ |
| Q1 2020 | Mar 31, 2020 | 8,893 | +35.9% | Form 10-Q (filed 2020-05-01) ↗ |
| Q4 2019 | Dec 31, 2019 | 8,319 | +33.2% | Form 10-K (filed 2020-02-13) ↗ |
| Q3 2019 | Sep 30, 2019 | 7,515 | +62.6% | Form 10-Q (filed 2019-10-31) ↗ |
| Q2 2019 | Jun 30, 2019 | 7,034 | +62.2% | Form 10-Q (filed 2019-08-01) ↗ |
| Q1 2019 | Mar 31, 2019 | 6,543 | +65.5% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 31, 2018 | 6,246 | +76.1% | Form 10-K (filed 2019-02-13) ↗ |
| Q3 2018 | Sep 30, 2018 | 4,621 | +44.5% | Form 10-Q (filed 2018-10-25) ↗ |
| Q2 2018 | Jun 30, 2018 | 4,335 | +32.0% | Form 10-Q (filed 2018-07-26) ↗ |
| Q1 2018 | Mar 31, 2018 | 3,953 | +34.2% | Form 10-Q (filed 2018-04-27) ↗ |
| Q4 2017 | Dec 31, 2017 | 3,546 | +22.4% | Form 10-K (filed 2018-02-15) ↗ |
| Q3 2017 | Sep 30, 2017 | 3,198 | +22.6% | Form 10-Q (filed 2017-10-30) ↗ |
| Q2 2017 | Jun 30, 2017 | 3,286 | +28.9% | Form 10-Q (filed 2017-07-28) ↗ |
| Q1 2017 | Mar 31, 2017 | 2,947 | +18.4% | Form 10-Q (filed 2017-04-28) ↗ |
| Q4 2016 | Dec 31, 2016 | 2,897 | +15.9% | Form 10-K (filed 2017-02-23) ↗ |
| Q3 2016 | Sep 30, 2016 | 2,610 | +7.2% | Form 10-Q (filed 2016-10-31) ↗ |
| Q2 2016 | Jun 30, 2016 | 2,549 | +7.4% | Form 10-Q (filed 2016-08-01) ↗ |
| Q1 2016 | Mar 31, 2016 | 2,488 | +14.9% | Form 10-Q (filed 2016-05-03) ↗ |
| Q4 2015 | Dec 31, 2015 | 2,499 | +7.0% | Form 10-Q (filed 2016-05-03) ↗ |
| Q3 2015 | Sep 30, 2015 | 2,434 | +1.2% | Form 10-Q (filed 2015-10-30) ↗ |
| Q2 2015 | Jun 30, 2015 | 2,374 | +12.1% | Form 10-Q (filed 2015-08-04) ↗ |
| Q1 2015 | Mar 31, 2015 | 2,166 | -1.4% | Form 10-Q (filed 2015-05-04) ↗ |
| Q4 2014 | Dec 31, 2014 | 2,335 | +0.7% | Form 10-K (filed 2015-02-13) ↗ |
| Q3 2014 | Sep 30, 2014 | 2,406 | -6.8% | Form 10-Q (filed 2014-11-06) ↗ |
| Q2 2014 | Jun 30, 2014 | 2,118 | -18.1% | Form 10-Q (filed 2014-07-31) ↗ |
| Q1 2014 | Mar 31, 2014 | 2,197 | -8.2% | Form 10-Q (filed 2014-05-05) ↗ |
| Q4 2013 | Dec 31, 2013 | 2,319 | -16.0% | Form 10-K (filed 2014-02-11) ↗ |
| Q3 2013 | Sep 30, 2013 | 2,583 | -5.0% | Form 10-Q (filed 2013-11-07) ↗ |
| Q2 2013 | Jun 30, 2013 | 2,584 | -0.8% | Form 10-Q (filed 2013-08-02) ↗ |
| Q1 2013 | Mar 31, 2013 | 2,392 | +2.0% | Form 10-Q (filed 2013-05-08) ↗ |
| Q4 2012 | Dec 31, 2012 | 2,759 | +25.2% | Form 10-K (filed 2013-03-01) ↗ |
| Q3 2012 | Sep 30, 2012 | 2,719 | +30.0% | Form 10-Q (filed 2012-11-06) ↗ |
| Q2 2012 | Jun 30, 2012 | 2,605 | +47.7% | Form 10-Q (filed 2012-08-08) ↗ |
| Q1 2012 | Mar 31, 2012 | 2,346 | +52.5% | Form 10-Q (filed 2012-05-10) ↗ |
| Q4 2011 | Dec 31, 2011 | 2,204 | +27.8% | Form 10-K (filed 2012-02-22) ↗ |
| Q3 2011 | Sep 30, 2011 | 2,092 | +10.8% | Form 10-Q (filed 2011-11-03) ↗ |
| Q2 2011 | Jun 30, 2011 | 1,763 | +6.6% | Form 10-Q (filed 2011-08-09) ↗ |
| Q1 2011 | Mar 31, 2011 | 1,539 | -13.1% | Form 10-Q (filed 2011-05-06) ↗ |
| Q4 2010 | Dec 31, 2010 | 1,725 | -11.8% | Form 10-K (filed 2011-02-17) ↗ |
| Q3 2010 | Sep 30, 2010 | 1,889 | – | Form 10-Q (filed 2010-10-28) ↗ |
| Q2 2010 | Jun 30, 2010 | 1,654 | – | Form 10-Q (filed 2010-08-03) ↗ |
| Q1 2010 | Mar 31, 2010 | 1,770 | – | Form 10-Q (filed 2010-05-03) ↗ |
| Q4 2009 | Dec 31, 2009 | 1,956 | – | Form 10-Q (filed 2010-05-03) ↗ |
Phân tách
balance Sheet — Total assets gồm những gì
- Cash and cash equivalents ($M)6,144 · Q2 2026
- Marketable securities ($M)1,709 · Q2 2026
- Accounts receivable, net ($M)2,134 · Q2 2026
- Inventories ($M)1,765 · Q2 2026
- Prepaid expenses and other current assets ($M)792 · Q2 2026
- Total current assets ($M)12,544 · Q2 2026
- Property and equipment, net ($M)1,665 · Q2 2026
- Goodwill ($M)1,088 · Q2 2026
- Intangible assets, net ($M)413 · Q2 2026
- Operating lease right-of-use assets ($M)1,663 · Q2 2026
- Deferred tax assets ($M)3,011 · Q2 2026
- Other noncurrent assets ($M)1,251 · Q2 2026
- Accounts payable ($M)430 · Q2 2026
- Accrued expenses ($M)3,179 · Q2 2026
- Other current liabilities ($M)329 · Q2 2026
- Total current liabilities ($M)3,938 · Q2 2026
- Noncurrent operating lease liabilities ($M)1,978 · Q2 2026
- Other long-term liabilities ($M)1,260 · Q2 2026
- Total liabilities ($M)7,175 · Q2 2026
- Additional paid-in capital ($M)4,506 · Q2 2026
- Retained earnings (accumulated deficit) ($M)15,691 · Q2 2026
- Accumulated other comprehensive income (loss) ($M)48.5 · Q2 2026
- Total stockholders' equity ($M)20,248 · Q2 2026
- Common shares outstanding at period-end (M)253 · Q2 2026
Trích dẫn dữ liệu này
StockData. (2026). Balance Sheet — Total assets ($M) của Vertex Pharmaceuticals, theo quý Q4 2009–Q2 2026 [Bộ dữ liệu]. Tổng hợp từ Hồ sơ SEC và tài liệu dành cho nhà đầu tư của Vertex Pharmaceuticals. https://stockdatahq.com/stocks/vrtx/kpis/fs-balance-sheet
Xem mọi chỉ số ở bảng KPI của Vertex Pharmaceuticals. Dữ liệu cập nhật Nov 2, 2026.
See a number that looks wrong?